Federal Register: Agency Information Collection Activities; Proposed Collection; Comment Request; Adverse Event Pilot Program for Medical Products
July 9, 2010 5:31 am | by U.S. Food & Drug Administration | CommentsThe FDA is announcing an opportunity for public comment on the proposed collection of certain information by the agency.
Cooper declares seminannual dividend of 3 cents
July 9, 2010 4:45 am | by The Associated Press | CommentsCooper Cos., a medical products maker, said Friday it will issue a semiannual dividend of 3 cents, payable on Aug. 5 to shareholders of record as of July 20.
Instant testing for sore throats wins CIMIT prize
July 8, 2010 7:34 pm | by EurekAlert | Comments(CIMIT) Imagine finding out before you leave the pediatrician's office if your child has strep throat, or even something more serious requiring a different treatment. A novel application for applying DNA "nanobarcodes" in a clinical assay could help primary-care physicians quickly...
Conceptus cuts outlook for 2Q, year; shares dive
July 8, 2010 3:45 pm | by The Associated Press | CommentsConceptus Inc. cut its second-quarter and full-year forecasts on Thursday, saying the weak economy and high unemployment are causing prospective patients to delay visits to doctors.The company, which makes a non-incisional permanent birth control method, said visits to doctors in the U.S. have...
Reportlinker Adds 2010 U.S. Ophthalmologists' Assessment of Eye Care Medication Brands
July 8, 2010 1:37 pm | by Bio-Medicine.Org | CommentsNEW YORK , July 8 /- Reportlinker.com announces that a new market research report is available in its catalogue: http://www.reportlinker.com/p0236247/2010-US-Ophthalmologists-Assessment... This study encompasses feedback provided by U.S. physicians on...
FDA Consumer Health Information: Using Malaria Medication For Leg Cramps Is Risky
July 8, 2010 1:37 pm | by Bio-Medicine.Org | CommentsSILVER SPRING, Md. , July 8 /PRNewswire-USNewswire/ -- People who use the malaria drug Qualaquin to treat or prevent nighttime leg cramps may want to talk to their health care professional. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) (Logo:...
Que She Herbal Supplement: Undeclared Drug Ingredients
July 8, 2010 1:31 pm | by U.S. Food & Drug Administration | CommentsHerbal product, sold as weight loss supplement, contains unlisted active pharmaceutical ingredients. Risk of serious side effects, especially in those with heart conditions.
Conference bursaries make malaria mission possible
July 8, 2010 10:39 am | by EurekAlert | Comments(BioMed Central) Today, BioMed Central announced a fund to help researchers in developing countries attend the conference, Parasite to Prevention. The conference, held in conjunction with Malaria Journal, takes place in Edinburgh UK, Oct. 20-22, 2010.
University of Manchester academics at international conference on geographic chemicals
July 8, 2010 10:39 am | by EurekAlert | Comments(University of Manchester) A major conference, organized by scientists at the University of Manchester to showcase vital work on the effect of geographic chemicals, begins today.
Nanotechnology: nanomaterials are widely used in commerce, but EPA faces challenges in regulating risk
July 8, 2010 10:39 am | by I-Micronews | CommentsNanotechnology involves the ability to control matter at the scale of a nanometer--one billionth of a meter. The world market for products that contain nanomaterials is expected to reach $2.6 trillion by 2015.
The thinnest, smoothest metallic lines in the world helps speed up miniaturisation of electronic devices
July 8, 2010 10:39 am | by I-Micronews | CommentsNew method creates super-thin, high integrity, continuous metal lines that surpass today?s semiconductor industry requirements.
Nichia to start sample shipment of green diode laser
July 8, 2010 10:39 am | by I-Micronews | CommentsNichia Corp will finally commercialize its green diode laser for use mainly in pico projectors.
Genzyme to transfer more manufacturing to Hospira
July 8, 2010 10:38 am | by Mass High Tech: The Journal of New England Technology | CommentsGenzyme Corp. is expanding a deal designed to transfer more so-called fill-finish manufacturing work to Hospira Worldwide Inc. – part of an agreement with the U.S. FDA to comply with an enforcement action against the Cambridge-based biotechnology company.
PEAK Surgical Introduces PEAK PlasmaBlade(R) 3.0S
July 8, 2010 10:37 am | by Bio-Medicine.Org | CommentsPALO ALTO, Calif. , July 8 /- PEAK Surgical, Inc. today announced the launch of the PEAK PlasmaBlade® 3.0S dissection device following 510(k) clearance from the U.S. Food and Drug Administration (FDA). This revolutionary product features a 3.0mm wide blade for even greater cutting...
Unprecedented Donation Made by Mrs. Lily Safra to the Institute for Brain and Spinal Cord Disorders in Paris
July 8, 2010 10:37 am | by Bio-Medicine.Org | CommentsPARIS , July 8, 2010 /- Professor Gerard Saillant , President of the Institute for Brain and Spinal Cord Disorders (ICM), announced today an unprecedented donation of EUR8,000,000 from Mrs. Lily Safra . It is the largest single donation made by a private individual to the ICM. Professor Saillant...


